Comparing Mirabegron vs Vibegron
| Mirabegron | Vibegron |
|
|---|
| Mirabegron | Vibegron |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Urinary Frequency, Overactive Bladder, Urinary Incontinence, Neurogenic Detrusor Overactivity. Mirabegron may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Overactive Bladder. Vibegron may also be used for purposes not listed in this medication guide. |
Related suggestions Overactive Bladder
|
|||||||
| More about Mirabegron | More about Vibegron | ||||||||
| Ratings & Reviews | |||||||||
|
Mirabegron has an average rating of 4.7 out of 10 from a total of 354 ratings on Drugs.com. 31% of reviewers reported a positive effect, while 51% reported a negative effect. |
Vibegron has an average rating of 7.7 out of 10 from a total of 211 ratings on Drugs.com. 68% of reviewers reported a positive effect, while 12% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Mirabegron side effects |
View all Vibegron side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
|
Lower cost generic |
N/A |
||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
View all Mirabegron prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
| Dosage Forms | |||||||||
|
N/A |
||||||||
| Brand Names | |||||||||
| Myrbetriq | Gemtesa | ||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
50 hours |
94 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 254 drugs are known to interact with Mirabegron:
|
A total of 147 drugs are known to interact with Vibegron:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
| Disease Interactions | |||||||||
| First Approval Date | |||||||||
|
June 28, 2012 |
December 23, 2020 |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
N/A |
||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
| Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Myrbetriq
Myrbetriq (mirabegron) is used to treat overactive bladder with symptoms of frequent or urgent ...
Gemtesa
Gemtesa (vibegron) is used to treat overactive bladder symptoms (OAB) in adults or men taking ...
Botox
Botox is used to treat chronic migraines, excessive sweating, bladder conditions, eye muscle ...
Estrace
Estrace (estradiol) is used to treat symptoms of menopause such as hot flashes and vaginal dryness ...
Detrol
Detrol is used to treat overactive bladder symptoms of urinary frequency, urgency, and ...
VESIcare
Vesicare is used to treat symptoms of overactive bladder such as incontinence and frequent ...
Ditropan
Ditropan XL (oxybutynin extended release) is used to treat the symptoms of overactive bladder ...
Estradiol Patch
Estradiol Patch is used for atrophic urethritis, atrophic vaginitis, breast cancer, palliative ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.